Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells

European Respiratory Journal

Volumn 26, Issue 3, 2005, Pages 549-552

  Milman, N ^a   Andersen, C B ^b   Burton, C M ^a   Iversen, M ^a  

^a Division of Lung Transplantation   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Donor; Granuloma; In situ hybridisation; Lung transplantation; Pulmonary; Sarcoidosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENMARK; EXPLANT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENDER; HEALTH CARE FACILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LUNG TRANSPLANTATION; MALE; MOLECULAR PROBE; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; SARCOIDOSIS; TRANSBRONCHIAL BIOPSY; X CHROMOSOME; Y CHROMOSOME;

ADULT; CHROMOSOMES, HUMAN, X; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; SARCOIDOSIS, PULMONARY; T-LYMPHOCYTES;

EID: 24644493247     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00127404     Document Type: Article

References (24)

1. Milman N. Is sarcoidosis an infectious disease? Review series in respiratory diseases. Stockholm. Helix Communications 1998; 1: 2-5.
2. Du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for micro-organisms in the pathogenesis of sarcoidosis? J Intern Med 2003; 253: 4-17.
3. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Dis 1999; 16: 149-173.
4. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic Countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 1990; 7: 50-57.
5. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic Countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990; 7: 113-118.
6. Milman N, Burton C, Andersen CB, Carlsen J, Iversen M. Lung transplantation for end-stage pulmonary sarcoidosis: outcome in a series of seven consecutive patients. Sarcoidosis Vasculitis Dif Lung Dis 2005; 22: (In press).
7. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 1996; 15: 1-15.
8. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
9. Walker S, Mikhail G, Banner N, et al. Medium term results of lung transplantation for end stage pulmonary sarcoidosis. Thorax 1998; 53: 281-284.
10. Nunley DR, Hattler B, Keenan RJ, et al. Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 93-100.
11. Bjortuft O, Foerster A, Boe J, Geiran O. Single lung transplantation as treatment for end stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient. J Heart Lung Transplant 1994; 13: 24-29.
12. Burke M, Stewart S, Ashcroft T, Corbishley C, Bishop P, Kjellström C. Biopsy diagnosis of disease recurrence after transplantation (TX) for pulmonary sarcoidosis: a multi-centre study. J Heart Lung Transplant 2001; 20: 154-155.
13. Johnson BA, Duncan SR, Ohori NP, et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Resp Dis 1993; 148: 1373-1377.
14. Judson MA. Lung transplantation for pulmonary sarcoidosis. Eur Respir J 1998; 11: 738-744.
15. Sheffield EA, Williams WJ. Pathology. Lung Biology in Health and Disease 1994; 73: 45-67.
16. Sheffield EA, Mitchell DN, Dewar A, Corrin B. The ultrastructural features of developing Kveim test granulomas. Sarcoidosis 1989; 6: Suppl. 1, 6-7.
17. Martinez FJ, Orens JB, Deeb M, et al. Recurrence of sarcoidosis following bilateral allogenic lung transplantation. Chest 1994; 106: 1597-1599.
18. Semenzato G, Agostini C. Lung transplantation in Sarcoidosis: lessons learned from immunology. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 21-23.
19. Agostini C, Trentin L, Facco M, et al. Role of IL-15, IL-2 and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996; 157: 910-918.
20. Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 21-23.
21. Szeto WY, Rosengard BR. Basic concepts in transplantation immunology and pharmacologic immunosuppression. In: Baumgartner WA, Reitz BR, Kasper E, Theodore J, eds. Heart and lung transplantation. 2nd Edn. London, WB Saunders Company, 2002; pp. 15-25.
22. Wyser CP, van Schalkwyk EM, Alheit B, Bardin PG, Joubert JR. Treatment of progressive pulmonary sarcoidosis with cyclosporine A. A randomised controlled trial. Am J Respir Crit Care Med 1997; 156: 1371-1376.
23. Luckraz H, Zagolin M, McNeil K, Wallwork J. Graft-versus-host disease in lung transplantation: 4 case reports and literature review. J Heart Lung Transplant 2003; 22: 691-697.
24. Wiebe BM, Mortensen SA, Petterson G, Svendsen UG, Andersen CB. Macrophage and lymphocyte chimerism in bronchoalveolar lavage cells from human lung allograft recipients. APMIS 2001; 109: 435-440.